Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians
暂无分享,去创建一个
A. Adebiyi | A. Aje | O. Ogah | D. Ojji | O. Oladapo | A. Adebayo | A. Falase
[1] R. Devereux,et al. Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. , 2005, American journal of hypertension.
[2] A. Adebiyi,et al. Correlates of left atrial size in Nigerian hypertensives. , 2005, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners.
[3] R. Devereux,et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. , 2005, American journal of hypertension.
[4] F. Magrini,et al. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives , 2001, Journal of Human Hypertension.
[5] F. Magrini,et al. Prevalence of Left Ventricular Hypertrophy and Carotid Thickening in a Large Selected Hypertensive Population: Impact of Different Echocardiographic and Ultrasonographic Diagnostic Criteria , 2001, Blood pressure.
[6] R. Devereux,et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. , 1999, Journal of the American College of Cardiology.
[7] P. Gosse,et al. Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? , 1999, Journal of Human Hypertension.
[8] G. Reboldi,et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. , 1996, The American journal of cardiology.
[9] D. Levy,et al. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). , 1996, The American journal of cardiology.
[10] J. Laragh,et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. , 1995, Journal of the American College of Cardiology.
[11] J. Ghali,et al. The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease , 1992, Annals of Internal Medicine.
[12] J. Laragh,et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.
[13] J. Laragh,et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.
[14] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .
[15] D. Levy,et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.
[16] J. Laragh,et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. , 1986, Journal of the American College of Cardiology.
[17] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[18] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[19] R. Devereux,et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. , 2000, Hypertension.
[20] J. Schwartz,et al. Association of carotid atherosclerosis and left ventricular hypertrophy. , 1995, Journal of the American College of Cardiology.